6-K Filing

TEVA PHARMACEUTICAL INDUSTRIES LTD CIK: 818686 Q3 2017

Filing Information

Form Type	6-K
Accession Number	`0001193125-17-330935`
Period End Date	20170930
Filing Date	20171102
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	teva-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 92 Cash Flow Statement 72 Comprehensive Income 36

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$680.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.56B	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$7.42B	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$7.52B	USD	Point-in-time
Inventories	`InventoryNet`	$4.95B	USD	Point-in-time
Inventories	`InventoryNet`	$5.06B	USD	Point-in-time
Assets Held For Sale	`AssetsHeldForSale`	$841.00M	USD	Point-in-time
Assets Held For Sale	`AssetsHeldForSale`	$1.28B	USD	Point-in-time
Prepaid Expenses	`PrepaidExpenses`	$1.63B	USD	Point-in-time
Prepaid Expenses	`PrepaidExpenses`	$1.20B	USD	Point-in-time
Other Current Assets	`OtherCurrentAssets`	$1.29B	USD	Point-in-time
Other Current Assets	`OtherCurrentAssets`	$581.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.23B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.23B	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.05B	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.24B	USD	Point-in-time
Deferred Income Taxes	`NonCurrentDeferredIncomeTaxes`	$536.00M	USD	Point-in-time
Deferred Income Taxes	`NonCurrentDeferredIncomeTaxes`	$625.00M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$8.07B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$8.00B	USD	Point-in-time
Identifiable intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$20.88B	USD	Point-in-time
Identifiable intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$21.49B	USD	Point-in-time
Goodwill	`Goodwill`	$39.39B	USD	Point-in-time
Goodwill	`Goodwill`	$44.41B	USD	Point-in-time
Total assets	`Assets`	$93.06B	USD	Point-in-time
Total assets	`Assets`	$86.08B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$3.28B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.73B	USD	Point-in-time
Sales Reserves And Allowances	`SalesReservesAndAllowances`	$7.66B	USD	Point-in-time
Sales Reserves And Allowances	`SalesReservesAndAllowances`	$7.84B	USD	Point-in-time
Trade payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.16B	USD	Point-in-time
Trade payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.37B	USD	Point-in-time
Employee Related Obligations	`EmployeeRelatedObligations`	$718.00M	USD	Point-in-time
Employee Related Obligations	`EmployeeRelatedObligations`	$859.00M	USD	Point-in-time
Accrued Expenses	`AccruedExpenses`	$3.40B	USD	Point-in-time
Accrued Expenses	`AccruedExpenses`	$2.58B	USD	Point-in-time
Liabilities Held For Sale	`LiabilitiesOfAssetsHeldForSales`	$116.00M	USD	Point-in-time
Liabilities Held For Sale	`LiabilitiesOfAssetsHeldForSales`	$38.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$847.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$836.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.49B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.94B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$4.91B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$5.41B	USD	Point-in-time
Other taxes and long term liabilities	`OtherLiabilitiesNoncurrent`	$1.64B	USD	Point-in-time
Other taxes and long term liabilities	`OtherLiabilitiesNoncurrent`	$1.96B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$31.97B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$32.52B	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$38.84B	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$39.58B	USD	Point-in-time
Total liabilities	`Liabilities`	$55.79B	USD	Point-in-time
Total liabilities	`Liabilities`	$58.06B	USD	Point-in-time
Preferred Shares	`PreferredStockValue`	$3.62B	USD	Point-in-time
Preferred Shares	`PreferredStockValue`	$3.62B	USD	Point-in-time
Ordinary shares	`CommonStockValue`	$54.00M	USD	Point-in-time
Ordinary shares	`CommonStockValue`	$54.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.41B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.47B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$13.61B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.87B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.96B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.71B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.20B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.16B	USD	Point-in-time
Treasury shares	`TreasuryStockValue`	$4.19B	USD	Point-in-time
Treasury shares	`TreasuryStockValue`	$4.15B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$28.67B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$33.34B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.62B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.66B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.30B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.99B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$93.06B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$86.08B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`SalesRevenueNet`	$16.93B	USD	3 Qtrs
Net revenues	`SalesRevenueNet`	$15.41B	USD	3 Qtrs
Net revenues	`SalesRevenueNet`	$5.61B	USD	1 Quarter
Net revenues	`SalesRevenueNet`	$5.56B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.97B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$8.64B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$2.76B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$6.94B	USD	3 Qtrs
Gross profit	`GrossProfit`	$8.47B	USD	3 Qtrs
Gross profit	`GrossProfit`	$8.28B	USD	3 Qtrs
Gross profit	`GrossProfit`	$2.64B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.80B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$545.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.49B	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$663.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.43B	USD	3 Qtrs
Selling and marketing expenses	`SellingAndMarketingExpense`	$860.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$2.73B	USD	3 Qtrs
Selling and marketing expenses	`SellingAndMarketingExpense`	$2.79B	USD	3 Qtrs
Selling and marketing expenses	`SellingAndMarketingExpense`	$940.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$310.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$838.00M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$330.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$925.00M	USD	3 Qtrs
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$1.21B	USD	3 Qtrs
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$550.00M	USD	1 Quarter
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$421.00M	USD	3 Qtrs
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$-410.00M	USD	1 Quarter
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$533.00M	USD	1 Quarter
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$324.00M	USD	3 Qtrs
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$-20.00M	USD	1 Quarter
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$674.00M	USD	3 Qtrs
Goodwill Impairment Charge	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill Impairment Charge	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Goodwill Impairment Charge	`GoodwillImpairmentLoss`	$6.10B	USD	3 Qtrs
Goodwill Impairment Charge	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$378.00M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$2.29B	USD	3 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$765.00M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-4.47B	USD	3 Qtrs
Financial expenses - net	`NonoperatingIncomeExpense`	$-150.00M	USD	1 Quarter
Financial expenses - net	`NonoperatingIncomeExpense`	$-259.00M	USD	1 Quarter
Financial expenses - net	`NonoperatingIncomeExpense`	$-704.00M	USD	3 Qtrs
Financial expenses - net	`NonoperatingIncomeExpense`	$-553.00M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$615.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.74B	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.17B	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$119.00M	USD	1 Quarter
Income taxes (Benefit)	`IncomeTaxExpenseBenefit`	$-462.00M	USD	3 Qtrs
Income taxes (Benefit)	`IncomeTaxExpenseBenefit`	$-494.00M	USD	1 Quarter
Income taxes (Benefit)	`IncomeTaxExpenseBenefit`	$464.00M	USD	3 Qtrs
Income taxes (Benefit)	`IncomeTaxExpenseBenefit`	$207.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$11.00M	USD	3 Qtrs
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$-10.00M	USD	3 Qtrs
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$-3.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.28B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$610.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$410.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.72B	USD	3 Qtrs
Net Income (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-17.00M	USD	3 Qtrs
Net Income (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	1 Quarter
Net Income (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Net Income (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	3 Qtrs
Net income (loss) attributable to Teva	`NetIncomeLoss`	$412.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$595.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-4.73B	USD	3 Qtrs
Net income (loss) attributable to Teva	`NetIncomeLoss`	$1.30B	USD	3 Qtrs
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$196.00M	USD	3 Qtrs
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$65.00M	USD	1 Quarter
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$195.00M	USD	3 Qtrs
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$64.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$1.11B	USD	3 Qtrs
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$348.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$530.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.92B	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	935.00M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	979.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	984.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	942.00M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.35	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-4.85	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.52	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.18	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.52	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-4.85	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.17	USD	3 Qtrs

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$1.28B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$610.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$410.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.72B	USD	3 Qtrs
Goodwill impairment charge	`ImpairmentOfGoodwill`	$6.10B	USD	3 Qtrs
Goodwill impairment charge	`ImpairmentOfGoodwill`	-	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.19B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.58B	USD	3 Qtrs
Venezuela impairment of net monetary assets	`VenezuelaRemeasurementImpact`	$45.00M	USD	3 Qtrs
Venezuela impairment of net monetary assets	`VenezuelaRemeasurementImpact`	$246.00M	USD	3 Qtrs
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$755.00M	USD	3 Qtrs
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-1.10B	USD	3 Qtrs
Deferred Income Taxes Net And Uncertain Tax Positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-397.00M	USD	3 Qtrs
Deferred Income Taxes Net And Uncertain Tax Positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-733.00M	USD	3 Qtrs
Research and development in process	`ResearchAndDevelopmentExpense`	$175.00M	USD	3 Qtrs
Research and development in process	`ResearchAndDevelopmentExpense`	$262.00M	USD	3 Qtrs
Impairment of long lived assets	`AssetImpairmentCharges`	$564.00M	USD	3 Qtrs
Impairment of long lived assets	`AssetImpairmentCharges`	$614.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$106.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$83.00M	USD	3 Qtrs
Other items	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-146.00M	USD	3 Qtrs
Other items	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-9.00M	USD	3 Qtrs
Net gain from sale of long-lived assets and investments	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$731.00M	USD	3 Qtrs
Net gain from sale of long-lived assets and investments	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$48.00M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.33B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.80B	USD	3 Qtrs
Acquisitions of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$35.87B	USD	3 Qtrs
Acquisitions of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-43.00M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$568.00M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$607.00M	USD	3 Qtrs
Purchases of investments and other assets	`PaymentToAquireMarketableSecuritiesAndOtherAssets`	$316.00M	USD	3 Qtrs
Purchases of investments and other assets	`PaymentToAquireMarketableSecuritiesAndOtherAssets`	$194.00M	USD	3 Qtrs
Proceeds from sales of business, investments and long-lived assets	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.80B	USD	3 Qtrs
Proceeds from sales of business, investments and long-lived assets	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.61B	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-15.00M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$277.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$572.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-34.94B	USD	3 Qtrs
Proceeds from issuance of ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$329.00M	USD	3 Qtrs
Proceeds from issuance of ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$329.00M	USD	3 Qtrs
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$1.32B	USD	3 Qtrs
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.63B	USD	3 Qtrs
Dividends paid on ordinary shares	`PaymentsOfDividendsCommonStock`	$957.00M	USD	3 Qtrs
Dividends paid on ordinary shares	`PaymentsOfDividendsCommonStock`	$814.00M	USD	3 Qtrs
Dividends paid on preferred shares	`PaymentsOfDividendsPreferredStock`	$195.00M	USD	3 Qtrs
Dividends paid on preferred shares	`PaymentsOfDividendsPreferredStock`	$191.00M	USD	3 Qtrs
Dividends Paid To Non Controlling Interest	`PaymentsOfDividendsToNonControllingInterest`	$38.00M	USD	3 Qtrs
Dividends Paid To Non Controlling Interest	`PaymentsOfDividendsToNonControllingInterest`	-	USD	3 Qtrs
Proceeds from exercise of options by employees	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from exercise of options by employees	`ProceedsFromStockOptionsExercised`	$34.00M	USD	3 Qtrs
Proceeds from long-term loans and other long-term liabilities	`ProceedsFromLongTermLoansAndOtherLongTermLiabilities`	$507.00M	USD	3 Qtrs
Proceeds from long-term loans and other long-term liabilities	`ProceedsFromLongTermLoansAndOtherLongTermLiabilities`	$25.25B	USD	3 Qtrs
Repayment of long-term loans And Other Long Term Liabilities	`RepaymentsOfLongTermDebt`	$1.00B	USD	3 Qtrs
Repayment of long-term loans And Other Long Term Liabilities	`RepaymentsOfLongTermDebt`	$50.00M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-69.00M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-143.00M	USD	3 Qtrs
Net cash used in (provided by) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.24B	USD	3 Qtrs
Net cash used in (provided by) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.92B	USD	3 Qtrs
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$36.00M	USD	3 Qtrs
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-164.00M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-308.00M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.39B	USD	3 Qtrs
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$680.00M	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.56B	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$680.00M	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.56B	USD	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$1.28B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$610.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$410.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.72B	USD	3 Qtrs
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-60.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$286.00M	USD	3 Qtrs
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.14B	USD	3 Qtrs
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$264.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$510.00M	USD	3 Qtrs
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$118.00M	USD	3 Qtrs
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$49.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-11.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-17.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$20.00M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-84.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-349.00M	USD	3 Qtrs
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$4.00M	USD	1 Quarter
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$1.00M	USD	1 Quarter
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$4.00M	USD	3 Qtrs
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-12.00M	USD	3 Qtrs
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$-199.00M	USD	1 Quarter
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$569.00M	USD	3 Qtrs
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$129.00M	USD	1 Quarter
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$-1.03B	USD	3 Qtrs
Comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$809.00M	USD	1 Quarter
Comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$716.00M	USD	3 Qtrs
Comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$-3.69B	USD	3 Qtrs
Comprehensive Income (loss)	`ComprehensiveIncomeNetOfTax`	$281.00M	USD	1 Quarter
Comprehensive income attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$75.00M	USD	3 Qtrs
Comprehensive income attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$31.00M	USD	1 Quarter
Comprehensive income attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$165.00M	USD	3 Qtrs
Comprehensive income attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$11.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$551.00M	USD	3 Qtrs
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$798.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$250.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.77B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.